Back to Compound Explorer

Spinosin

Moderate

Mechanism of Action

Spinosin (2"-O-beta-glucopyranosyl swertisin) modulates the serotonergic system by acting as a partial agonist at 5-HT1A receptors, which mediate anxiolytic and sleep-promoting effects. It also potentiates GABAergic transmission through allosteric interaction with GABA-A receptors at a site distinct from the benzodiazepine binding site. Spinosin has additionally been shown to reduce norepinephrine turnover in the locus coeruleus, contributing to its sedative profile.

Research Notes

A 2020 study in Phytomedicine demonstrated that spinosin at 15 mg/kg significantly reduced sleep onset latency and increased NREM sleep duration in freely moving rats, effects that were blocked by the 5-HT1A antagonist WAY-100635. In vitro binding assays confirmed affinity for 5-HT1A receptors with a Ki of approximately 8.5 uM. Multiple animal behavioral studies have confirmed dose-dependent anxiolytic activity in the elevated plus-maze and open field tests.

Found In 1 Herb

3D Molecular Structure

Flavonoid C-glycoside
Drag to rotate · Click atoms to explore

Spinosin

Flavonoid C-glycosidePolyphenolic antioxidants protecting cells from oxidative damage

Representative pattern: C₁₅H₁₀O₃

Atoms
Carbon
Oxygen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.